Literature DB >> 10646685

Comprehensive review of the psychiatric uses of valproate.

L L Davis1, W Ryan, B Adinoff, F Petty.   

Abstract

The therapeutic effects of valproate in psychiatric conditions are most substantially recognized in bipolar disorder. However, this well-tolerated medication may be beneficial in the treatment of other mental illnesses. In this article, the authors comprehensively review studies of valproate as treatment for psychiatric conditions, including bipolar, depressive, anxiety, and psychotic disorders; alcohol withdrawal and dependence; tardive dyskinesia; agitation associated with dementia; and borderline personality disorder. Valproate shows the most promising efficacy in treating mood and anxiety disorders, with possible efficacy in the treatment of agitation and impulsive aggression, and less convincing therapeutic response in treating psychosis and alcohol withdrawal or dependence. The authors conclude with a brief summary of its mechanism of action and therapeutic spectrum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646685     DOI: 10.1097/00004714-200002001-00001

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  16 in total

1.  Psychiatric Uses of Newer Anticonvulsants.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

Review 2.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

3.  The effect of sodium valproate on acetic acid-induced colitis in rats.

Authors:  Ali Najafi; Ehsan Motaghi; Mohammad Javad Hosseini; Masoumeh Ghasemi-Pirbaluti
Journal:  Inflammopharmacology       Date:  2016-12-31       Impact factor: 4.473

4.  Low-dose tiagabine effectiveness in anxiety disorders.

Authors:  James L Schaller; John Thomas; David Rawlings
Journal:  MedGenMed       Date:  2004-09-17

Review 5.  The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure.

Authors:  Per Bech
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  The use of newer anticonvulsants in neuropsychiatric disorders.

Authors:  Edward Kim
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

7.  Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.

Authors:  Anita Rakic Ignjatovic; Branislava Miljkovic; Dejan Todorovic; Ivana Timotijevic; Milena Pokrajac
Journal:  Br J Clin Pharmacol       Date:  2008-12-05       Impact factor: 4.335

8.  Screening of potential small volume resuscitation products using a severe hemorrhage sedated swine model.

Authors:  John W Burns; Lisa A Baer; Daniel N Darlington; Michael A Dubick; Charles E Wade
Journal:  Int J Burns Trauma       Date:  2012-03-15

Review 9.  Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges.

Authors:  Salia Farrokh; Christina Roels; Kent A Owusu; Sarah E Nelson; Aaron M Cook
Journal:  Neurocrit Care       Date:  2020-08-13       Impact factor: 3.210

Review 10.  Valproate for schizophrenia.

Authors:  Yijun Wang; Jun Xia; Bartosz Helfer; Chunbo Li; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2016-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.